Your account is not claimed yet. You can sign up with ORCID to claim your account.

Hiroaki Wakiyama

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 13

Top Venues

Cancers

Cancer science

Molecular cancer therapeutics

Biomedicines

National Cancer Institute

This page only lists publications with an associated author ORCID identifier.

Affiliation History

National Cancer Institute Apr 8o 2019

United States

Postodoctoral Fellow (Visiting) :: Molecular Imaging Program

Publications

Hiroshi Fukushima, Aki Furusawa, Takuya Kato, Hiroaki Wakiyama, Seiichiro Takao, Shuhei Okuyama, Peter C Black, Hisataka Kobayashi
Intratumoral interleukin-15 improves efficacy of near-infrared photoimmunotherapy. Molecular cancer therapeutics (2023)
Hiroaki Wakiyama, Takuya Kato, Aki Furusawa, Ryuhei Okada, Fuyuki F Inagaki, Hideyuki Furumoto, Hiroshi Fukushima, Shuhei Okuyama, Peter C Black, Hisataka Kobayashi
Treg-Dominant Tumor Microenvironment Is Responsible for Hyperprogressive Disease after PD-1 Blockade Therapy. Cancer immunology research 10 (11) (2022)
Hideyuki Furumoto, Takuya Kato, Hiroaki Wakiyama, Aki Furusawa, Peter L Choyke, Hisataka Kobayashi
Endoscopic Applications of Near-Infrared Photoimmunotherapy (NIR-PIT) in Cancers of the Digestive and Respiratory Tracts. Biomedicines 10 (4) (2022)
Takuya Kato, Aki Furusawa, Ryuhei Okada, Fuyuki F Inagaki, Hiroaki Wakiyama, Hideyuki Furumoto, Hiroshi Fukushima, Shuhei Okuyama, Peter C Black, Hisataka Kobayashi
Near-Infrared Photoimmunotherapy Targeting Podoplanin-Expressing Cancer Cells and Cancer-Associated Fibroblasts. Molecular cancer therapeutics (2022)
Hiroshi Fukushima, Takuya Kato, Aki Furusawa, Ryuhei Okada, Hiroaki Wakiyama, Hideyuki Furumoto, Shuhei Okuyama, Eisaku Kondo, Peter L Choyke, Hisataka Kobayashi
Intercellular adhesion molecule-1-targeted near-infrared photoimmunotherapy of triple-negative breast cancer. Cancer science 113 (9) (2022)
Takuya Kato, Hiroaki Wakiyama, Aki Furusawa, Peter L Choyke, Hisataka Kobayashi
Near Infrared Photoimmunotherapy; A Review of Targets for Cancer Therapy. Cancers 13 (11) (2021)
Fuyuki F Inagaki, Daiki Fujimura, Aki Furusawa, Ryuhei Okada, Hiroaki Wakiyama, Takuya Kato, Peter L Choyke, Hisataka Kobayashi
Diagnostic imaging in near-infrared photoimmunotherapy using a commercially available camera for indocyanine green. Cancer science 112 (3) (2021)
Hiroaki Wakiyama, Takuya Kato, Aki Furusawa, Peter L Choyke, Hisataka Kobayashi
Near infrared photoimmunotherapy of cancer; possible clinical applications. Nanophotonics 10 (12) (2021)
Adrian Rosenberg, Daiki Fujimura, Ryuhei Okada, Aki Furusawa, Fuyuki Inagaki, Hiroaki Wakiyama, Takuya Kato, Peter L Choyke, Hisataka Kobayashi
Real-Time Fluorescence Imaging Using Indocyanine Green to Assess Therapeutic Effects of Near-Infrared Photoimmunotherapy in Tumor Model Mice. Molecular imaging 19 (2021)
Ryuhei Okada, Aki Furusawa, Fuyuki F Inagaki, Hiroaki Wakiyama, Takuya Kato, Shuhei Okuyama, Hideyuki Furumoto, Hiroshi Fukushima, Peter L Choyke, Hisataka Kobayashi
Endoscopic near-infrared photoimmunotherapy in an orthotopic head and neck cancer model. Cancer science 112 (8) (2021)
Hiroaki Wakiyama, Aki Furusawa, Ryuhei Okada, Fuyuki F Inagaki, Takuya Kato, Yasuhiro Maruoka, Peter L Choyke, Hisataka Kobayashi
Increased Immunogenicity of a Minimally Immunogenic Tumor after Cancer-Targeting Near Infrared Photoimmunotherapy. Cancers 12 (12) (2020)
Yasuhiro Maruoka, Aki Furusawa, Ryuhei Okada, Fuyuki F Inagaki, Hiroaki Wakiyama, Takuya Kato, Tadanobu Nagaya, Peter L Choyke, Hisataka Kobayashi
Interleukin-15 after Near-Infrared Photoimmunotherapy (NIR-PIT) Enhances T Cell Response against Syngeneic Mouse Tumors. Cancers 12 (9) (2020)
Yasuhiro Maruoka, Aki Furusawa, Ryuhei Okada, Fuyuki F Inagaki, Daiki Fujimura, Hiroaki Wakiyama, Takuya Kato, Tadanobu Nagaya, Peter L Choyke, Hisataka Kobayashi
Near-Infrared Photoimmunotherapy Combined with CTLA4 Checkpoint Blockade in Syngeneic Mouse Cancer Models. Vaccines 8 (3) (2020)

Hiroaki Wakiyama.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Hiroaki Wakiyama